Nanoparticles for Liver Failure and Cancer: How “Smart” Drugs Know Where to Act

In cases of liver failure or cancer, a drug should reach the affected tissue as quickly and efficiently as possible—without causing side effects that could damage other organs. 

The Jena-based company SmartDyeLivery has developed small nanocarriers for this targeted drug delivery, which can transport active ingredients directly to a target cell and release them in precise doses.

At the LNDW, the SmartDyeLivery developers from the InfectoGnostics Research Campus will demonstrate how these tiny nanoparticles work using a large, hands-on model and explain potential medical applications of the technology.